rs879253748
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_001127644.2(GABRA1):c.1200delC(p.Lys401SerfsTer25) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001127644.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 19 Pathogenic:1
The herewith reported de novo deletion of one base pair (c.1200del) in the last exon of GABRA1 is located downstream of the last splice junction and thus probably escapes nonsense-mediated mRNA decay. The variant is predicted to cause frameshifting and a premature translational stop codon (p.(Lys401Serfs*25)), changing or truncating the last 56 residues of the protein and thus lacking part of the intracellular loop between the last two transmembrane domains and the complete C-terminal transmembrane domain. In the literature, similar variants in GABRA1 and also in other GABA-A subunits have already been associated with disease. Functional studies for these variants could demonstrate a disrupted surface expression, hence leading to a change in subunit composition with reduction of GABA-A mediated inhibition resulting in a predisposition to seizures. Taken together the de novo status of the herewith identified GABRA1 variant c.1200del, the matching phenotype of the patient and the descriptions in the literature argue for the pathogenicity of this variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at